A detailed history of Murphy, Middleton, Hinkle & Parker, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Murphy, Middleton, Hinkle & Parker, Inc. holds 5,410 shares of MDT stock, worth $419,870. This represents 0.27% of its overall portfolio holdings.

Number of Shares
5,410
Previous 5,822 7.08%
Holding current value
$419,870
Previous $479,000 1.67%
% of portfolio
0.27%
Previous 0.3%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$82.84 - $88.09 $34,130 - $36,293
-412 Reduced 7.08%
5,410 $471,000
Q4 2023

Jan 24, 2024

SELL
$69.43 - $83.43 $83,593 - $100,449
-1,204 Reduced 17.14%
5,822 $479,000
Q3 2023

Oct 03, 2023

BUY
$78.22 - $90.4 $31,288 - $36,160
400 Added 6.04%
7,026 $550,000
Q2 2023

Jul 05, 2023

SELL
$79.47 - $91.38 $31,788 - $36,552
-400 Reduced 5.69%
6,626 $583,000
Q1 2023

Apr 05, 2023

SELL
$76.72 - $87.58 $7,672 - $8,758
-100 Reduced 1.4%
7,026 $566,000
Q4 2022

Jan 17, 2023

BUY
$76.18 - $87.74 $2,285 - $2,632
30 Added 0.42%
7,126 $554,000
Q3 2022

Oct 07, 2022

SELL
$80.75 - $95.31 $7,671 - $9,054
-95 Reduced 1.32%
7,096 $573,000
Q3 2021

Oct 07, 2021

SELL
$122.75 - $135.17 $32,528 - $35,820
-265 Reduced 3.55%
7,191 $901,000
Q1 2021

Apr 08, 2021

SELL
$111.18 - $119.74 $4,447 - $4,789
-40 Reduced 0.53%
7,456 $881,000
Q4 2020

Jan 12, 2021

SELL
$100.57 - $117.14 $22,929 - $26,707
-228 Reduced 2.95%
7,496 $878,000
Q4 2019

Jan 08, 2020

SELL
$104.49 - $114.54 $52,140 - $57,155
-499 Reduced 6.07%
7,724 $876,000
Q1 2019

Apr 17, 2019

SELL
$82.45 - $93.79 $44,523 - $50,646
-540 Reduced 6.16%
8,223 $749,000
Q2 2018

Jul 13, 2018

BUY
$77.48 - $87.83 $678,957 - $769,654
8,763 New
8,763 $750,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Murphy, Middleton, Hinkle & Parker, Inc. Portfolio

Follow Murphy, Middleton, Hinkle & Parker, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy, Middleton, Hinkle & Parker, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Murphy, Middleton, Hinkle & Parker, Inc. with notifications on news.